Previous Close | 92.06 |
Open | 92.69 |
Bid | 91.12 x 100 |
Ask | 91.31 x 300 |
Day's Range | 91.01 - 93.01 |
52 Week Range | 76.02 - 99.56 |
Volume | |
Avg. Volume | 1,412,556 |
Market Cap | 17.307B |
Beta (5Y Monthly) | 0.32 |
PE Ratio (TTM) | 104.83 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Explore key financial achievements and strategic directions from Biomarin's latest earnings call.
The headline numbers for BioMarin (BMRN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Strong Performance Driven by VOXZOGO Sales and Strategic R&D Focus